Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
Completed
- Conditions
- Post Hematopoietic Stem Cell Transplantation
- Registration Number
- NCT01420172
- Lead Sponsor
- Karen Wood
- Brief Summary
This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
This study will determine factors influencing pulmonary disease and associated treatment strategies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Adult patients who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
- Age > 18 years
Exclusion Criteria
- Age <18 years
- Prisoners
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation. Up to 15 years To determine factors influencing pulmonary disease related to HSCT.
- Secondary Outcome Measures
Name Time Method A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation. Up to 15 years To review treatment strategies for pulmonary disease post transplant for effectiveness.
Trial Locations
- Locations (1)
The Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States
The Ohio State University Medical Center🇺🇸Columbus, Ohio, United States